A Study of KD6005 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)

Conditions: Rheumatoid Arthritis Interventions: Drug: KD6005; Drug: Placebo Sponsors: Shanghai Kanda Biotechnology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials